Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,368 | 955 | 99.7% |
| Education | $26.97 | 5 | 0.2% |
| Travel and Lodging | $15.63 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,175 | 122 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,060 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,963 | 110 | $0 (2024) |
| ABBVIE INC. | $1,430 | 88 | $0 (2024) |
| Lilly USA, LLC | $1,146 | 81 | $0 (2024) |
| PFIZER INC. | $912.78 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $787.32 | 51 | $0 (2024) |
| Amgen Inc. | $725.92 | 47 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $679.26 | 36 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $558.58 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,014 | 121 | ABBVIE INC. ($346.63) |
| 2023 | $2,015 | 128 | GlaxoSmithKline, LLC. ($446.20) |
| 2022 | $2,124 | 124 | ABBVIE INC. ($474.40) |
| 2021 | $2,201 | 140 | AbbVie Inc. ($333.86) |
| 2020 | $895.66 | 60 | Novo Nordisk Inc ($169.61) |
| 2019 | $1,779 | 118 | AstraZeneca Pharmaceuticals LP ($393.20) |
| 2018 | $2,351 | 137 | GlaxoSmithKline, LLC. ($511.10) |
| 2017 | $2,031 | 133 | Supernus Pharmaceuticals, Inc. ($329.65) |
All Payment Transactions
961 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Oncology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: VACCINES | ||||||
| 11/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: PAIN | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: VACCINE | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 10/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 64 | 6,911 | 13,905 | $949,330 | $409,967 |
| 2022 | 60 | 7,329 | 14,275 | $948,531 | $391,439 |
| 2021 | 62 | 7,425 | 13,933 | $922,117 | $382,804 |
| 2020 | 57 | 8,031 | 14,773 | $1.0M | $375,685 |
All Medicare Procedures & Services
243 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 315 | 1,781 | $318,799 | $149,721 | 47.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 265 | 746 | $63,410 | $34,811 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 215 | 215 | $35,690 | $25,975 | 72.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 138 | 140 | $25,340 | $20,020 | 79.0% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 156 | 241 | $24,582 | $15,235 | 62.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 244 | $33,184 | $14,865 | 44.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 192 | 193 | $18,335 | $14,631 | 79.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 281 | 789 | $46,551 | $10,229 | 22.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 298 | 1,039 | $10,390 | $8,678 | 83.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 282 | 945 | $34,965 | $7,795 | 22.3% |
| 80076 | Liver function blood test panel | Office | 2023 | 279 | 818 | $29,448 | $6,527 | 22.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 282 | 864 | $30,240 | $6,526 | 21.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 204 | 205 | $10,250 | $5,879 | 57.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 226 | 246 | $16,728 | $5,600 | 33.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 138 | 140 | $7,000 | $5,355 | 76.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 169 | 179 | $8,413 | $5,168 | 61.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 40 | $9,680 | $5,056 | 52.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 249 | 308 | $13,552 | $5,011 | 37.0% |
| 99437 | Chronic care management services for two or more chronic conditions, additional 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 69 | 109 | $10,355 | $4,632 | 44.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 215 | 215 | $6,450 | $3,638 | 56.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 215 | 215 | $7,525 | $3,621 | 48.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 44 | 44 | $4,400 | $3,357 | 76.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 140 | 354 | $13,452 | $3,342 | 24.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 100 | 324 | $19,440 | $3,013 | 15.5% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 13 | 13 | $3,250 | $2,895 | 89.1% |
About Dr. Zeming Deng, M.D
Dr. Zeming Deng, M.D is a Family Medicine healthcare provider based in Midwest City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659363463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zeming Deng, M.D has received a total of $15,411 in payments from pharmaceutical and medical device companies, with $2,014 received in 2024. These payments were reported across 961 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($15,368).
As a Medicare-enrolled provider, Deng has provided services to 29,696 Medicare beneficiaries, totaling 56,886 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 243 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Midwest City, OK
- Active Since 08/17/2005
- Last Updated 11/29/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659363463
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,125
- FARXIGA (Drug) $969.06
- Ozempic (Drug) $890.25
- QULIPTA (Drug) $673.12
- TROKENDI XR (Drug) $662.33
- JARDIANCE (Drug) $600.42
- UBRELVY (Drug) $556.37
- Tresiba (Drug) $541.38
- Aimovig (Biological) $472.60
- ANORO (Drug) $410.56
- TRULICITY (Drug) $401.21
- SYMBICORT (Drug) $392.43
- NURTEC ODT (Drug) $391.11
- TRINTELLIX (Drug) $385.99
- EMGALITY (Drug) $342.73
- VRAYLAR (Drug) $302.02
- JANUVIA (Drug) $292.04
- BREO (Drug) $282.58
- AIRSUPRA (Drug) $278.95
- Rybelsus (Drug) $271.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midwest City
Aubrey Kavanaugh, M.d, M.D
Family Medicine — Payments: $15,125
Melvin Cook, Md, MD
Family Medicine — Payments: $13,195
Dr. Michael Anderson, Md, MD
Family Medicine — Payments: $12,118
Tanner Mcdaniel, Md, MD
Family Medicine — Payments: $11,976
Dr. Joshua Smith, M.d, M.D
Family Medicine — Payments: $10,425
Dr. Timothy Moser, D.o, D.O
Family Medicine — Payments: $3,021